Lineage Therap(IL:LCTX)
ILA 294.70-17.30 (-5.54%)
IL:LCTX
Lineage Therap earnings date
ILA 294.70
At close:-17.30 (-5.54%)
Lineage Therap (LCTX) Q4 2023 Earnings Report
3 Followers
IL:LCTX Q4 2023 EPS Results
- Actual EPS
- -ILA 9.65
- Consensus EPS
- -ILA 13.83
- Beat/Miss
- Beat by +ILA 4.18
- One Year Ago EPS
- -ILA 9.65
IL:LCTX Q4 2023 Revenue Results
- Actual Revenue
- ILA 671.65M
- Expected Revenue
- ILA 850.17M
- Beat/Miss
- Missed by -ILA 178.53M
- YoY Revenue Growth
- +9.03%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 03/07/2024
- Time
- After Close
- Conference Call
- Thursday, March 7, 2024
IL:LCTX Upcoming Earnings
Lineage Therap's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
IL:LCTX Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
IL:LCTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -7.40- | 1.29 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -9.33-9.65 | -41.82 | 76.92% (+32.17) | |
| Aug 06, 2026 | 2026 (Q2) | -9.01-9.65 | -41.82 | 76.92% (+32.17) | |
| May 12, 2026 | 2026 (Q1) | -6.43-9.65 | -6.43 | -50.00% (-3.22) | |
| Mar 05, 2026 | 2025 (Q4) | -13.831.29 | -6.43 | 120.00% (+7.72) | |
| Nov 06, 2025 | 2025 (Q3) | -8.36-41.82 | -6.43 | -550.00% (-35.38) | |
| Aug 12, 2025 | 2025 (Q2) | -8.69-41.82 | -9.65 | -333.33% (-32.17) | |
| May 13, 2025 | 2025 (Q1) | -8.36-6.43 | -12.87 | 50.00% (+6.43) | |
| Mar 10, 2025 | 2024 (Q4) | -9.65-6.43 | -9.65 | 33.33% (+3.22) | |
| Nov 14, 2024 | 2024 (Q3) | -12.87-6.43 | -12.87 | 50.00% (+6.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

